Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis ...

The Type C meeting represents a formal opportunity for Merakris to engage with the FDA under its active Investigational New Drug (IND) application for the treatment of venous leg ulcers. The meeting ...

-- Following Positive Topline Data in RECONNECT Phase 2 Trial, Expect to Initiate Phase 3 Trial of RE104 in Postpartum Depression (PPD) in 2026 and RECLAIM Phase 2 Trial in Generalized Anxiety ...

Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through ...

Approved by the European Commission in May 2025 with a total budget of €13.6 million, PREDI-LYNCH is a six-year (2025–2031) Horizon Europe initiative coordinated by Oslo University Hospital (OUS) and ...

Mesquite, NV — Dogecoin Cash Inc. (OTCQB:DOGP) today announced that its Board of Directors has approved a special distribution of DogeCoin Cash (MEMECOIN:DOG) to shareholders of record as of December ...

A digital version of the presentation can be found on the Publications section of the Upstream Bio website.

LONDON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pulselight, a data analytics company that has developed software AI products capable of transforming the UK health system, today announces the appointment of ...

Long-term antibody persistence is a key competitive advantage for a vaccine targeting unpredictable outbreak diseases like chikungunya ...

Invested in Stalicla SA, confirming commitment to advancing innovative treatments for CNS disorders ...

Basel, 30 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity ...

MagnetOs MIS sets a new standard in minimally invasive surgery as the only bone graft delivery system that is sterile, prefilled, free of human tissue, and with a mechanism of action backed by Level I ...